1. Home
  2. CYTK vs AGX Comparison

CYTK vs AGX Comparison

Compare CYTK & AGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$61.52

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$475.02

Market Cap

6.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
AGX
Founded
1997
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.2B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
CYTK
AGX
Price
$61.52
$475.02
Analyst Decision
Strong Buy
Buy
Analyst Count
18
4
Target Price
$88.50
$321.00
AVG Volume (30 Days)
1.8M
308.3K
Earning Date
05-05-2026
03-26-2026
Dividend Yield
N/A
0.42%
EPS Growth
N/A
157.32
EPS
N/A
6.27
Revenue
$13,368,000.00
$874,179,000.00
Revenue This Year
$8.73
$8.95
Revenue Next Year
$309.93
$27.89
P/E Ratio
N/A
$76.81
Revenue Growth
N/A
52.47
52 Week Low
$29.31
$111.16
52 Week High
$70.98
$492.70

Technical Indicators

Market Signals
Indicator
CYTK
AGX
Relative Strength Index (RSI) 45.86 60.54
Support Level $59.13 $201.74
Resistance Level $65.72 N/A
Average True Range (ATR) 2.57 25.62
MACD 0.03 -0.68
Stochastic Oscillator 49.44 79.83

Price Performance

Historical Comparison
CYTK
AGX

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

Share on Social Networks: